author-photo

Yanín Bebelagua

Center of Molecular Immunology

4

Papers

158

Citations

Citation Trend

Filter By

Papers (3) Sort By

Journal Conference Others

Direct validation of NGcGM3 ganglioside as a new target for cancer immunotherapy

2010 Expert Opinion on Biological Therapy
Show All
- Source
- Cite
- Save
Citations (32)
La variante N-glicolilada del gangliósido GM3 en la biología de los tumores: un blanco atractivo para la inmunoterapia del cáncer

2008 Biotecnología Aplicada
Show All
- Source
- Cite
- Save
Citations (2)
Immunotherapy of Advanced Breast Cancer With a Heterophilic Ganglioside (NeuGcGM3) Cancer Vaccine

2003 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (87)